Insulin delivery apparatuses capable of bluetooth data transmission

• US 10,685,749 B2
• Filed: 12/28/2015
• Issued: 06/16/2020
• Est. Priority Date: 12/19/2007
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Hayter, Gary A., Dunn, Timothy C.
• Primary Examiner(s): Burgess, Joseph D
• Application Number:
  US14/981,863
• Publication Number:
  US 20160106919A1
• Time in Patent Office: 1,632 Days
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/18 with alarm
• CPC Class Codes: A61M 2205/3584 using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/50 with microprocessors or computers
• CPC Class Codes: A61M 2205/502 User interfaces, e.g. screens or keyboards
• CPC Class Codes: A61M 2205/52 with memories providing a history of measured variating parameters of apparatus or patient
• CPC Class Codes: A61M 2205/582 by tactile feedback
• CPC Class Codes: A61M 2230/005 Parameter used as control input for the apparatus
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/142 Pressure infusion, e.g. using pumps
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00
• CPC Class Codes: G06F 2218/16 by matching signal segments
• CPC Class Codes: G06F 3/04847 Interaction techniques to control parameter settings, e.g. interaction with sliders or dials
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 20/60 relating to nutrition control, e.g. diets
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders
• CPC Class Codes: H04W 4/80 Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication

Abstract

Method and system including displaying a first representation of a medication treatment parameter profile, displaying a first representation of a physiological profile associated with the medication treatment parameter profile, detecting a modification to a segment of the medication treatment parameter profile, displaying a modified representation of the medication treatment parameter profile and the physiological profile based on the detected modification to the segment of the medication treatment parameter profile, modifying an attribute of the first representation of the medication treatment parameter profile, and modifying an attribute of the first representation of the physiological profile are provided.

Claims

1. A system comprising:

a data receiver configured to receive, over a communication link, information corresponding to a detected glucose level of a user from an analyte sensor;

an insulin infusion device communicatively coupled with the data receiver and configured to deliver insulin to the user'"'"'s body;

one or more processors communicatively coupled with the data receiver and the insulin infusion device, at least one of the one or more processors programmed to control the delivery of insulin from the insulin infusion device based on the information corresponding to the detected glucose level of the user and a modified glucose level;

a display unit communicatively coupled to the one or more processors and a memory, wherein the memory stores instructions that, when executed by the one or more processors, causes the one or more processors to simultaneously display on the display unit;

a first representation of an insulin treatment parameter profile comprising a vertical basal insulin axis and a first trace line of basal insulin over a horizontal time scale represented by at least one time axis;

a modified representation of the insulin treatment parameter profile comprising the vertical basal insulin axis and a second trace line of basal insulin over the horizontal time scale based on a detected horizontal and/or vertical user modification to the first trace line of basal insulin;

a first representation of a physiological profile associated with the insulin treatment parameter profile comprising a vertical glucose parameter axis and a first trace line of a glucose parameter over the horizontal time scale; and

a modified representation of the physiological profile comprising the vertical glucose parameter axis and a second trace line of the glucose parameter over the horizontal time scale based on a determined corresponding modification to the glucose parameter due to the detected user modification to the first trace line of basal insulin, wherein the second trace line of the glucose parameter comprises the modified glucose level.

2. The system of claim 1, further comprising an infusion tube and an infusion cannula, the infusion tube coupled with the insulin infusion device.

3. The system of claim 1, further comprising a data transmitter configured to transmit the information corresponding to the detected glucose level from the analyte sensor and to the data receiver over the communication link.

4. The system of claim 3, wherein the data transmitter is configured to transmit the information corresponding to the detected glucose level of the user over the Bluetooth communication link substantially in real time.

5. The system of claim 4, wherein the data transmitter is configured to transmit information corresponding to a plurality of detected glucose levels substantially in real time over a predefined time period, and wherein the one or more processors are further programmed to control the delivery of insulin from the insulin infusion device based on a rate of change of the detected glucose levels over the predefined time period.

6. The system of claim 3, wherein the communication link is a Bluetooth communication link.

7. The system of claim 1, wherein the memory further stores instructions that, when executed by the one or more processors, causes the one or more processors to modify a visual attribute associated with the physiological profile without modifying an underlying value associated with the first representation of the physiological profile, and to modify a visual attribute associated with the first representation of the insulin treatment parameter profile without modifying the underlying value associated with the insulin treatment parameter profile.

8. The system of claim 1, wherein the memory further stores instructions which, when executed by the one or more processors, causes the one or more processors to display one or more boundaries associated with the physiological profile.

9. The system of claim 8, wherein the memory further stores instructions which, when executed by the one or more processors, causes the one or more processors to output an error indication when the modified representation of the physiological profile exceeds the one or more boundaries.

10. The system of claim 1, wherein the memory further stores instructions which, when executed by the one or more processors, causes the one or more processors to monitor data related to the physiological profile based on a rate of change of the physiological profile, and determine trend data based on the rate of change of the physiological profile.

11. The system of claim 1, wherein the glucose parameter of the physiological profile includes at least one of a median glucose profile, an upper quartile glucose profile, and a lower quartile glucose profile.

12. The system of claim 1, wherein the glucose parameter of the physiological profile includes a median glucose profile, an upper quartile glucose profile, and a lower quartile glucose profile.

13. The system of claim 1, wherein the horizontal time scale is represented by a first time axis in the first representation of the insulin treatment parameter profile, and wherein the horizontal time scale is represented by a second time axis in the first representation of the physiological profile.

14. A system comprising:

a data receiver configured to receive, over a communication link, information corresponding to a detected analyte level of a user from an analyte sensor;

a medication delivery device communicatively coupled with the data receiver and configured to deliver medication to the user'"'"'s body;

one or more processors communicatively coupled with the data receiver and the medication delivery device, at least one of the one or more processors programmed to control the delivery of the medication from the medication delivery device based on the information corresponding to the detected analyte level of the user and a modified analyte level;

a display unit communicatively coupled to the one or more processors and a memory, wherein the memory stores instructions that, when executed by the one or more processors, causes the one or more processors to simultaneously display on the display unit;

a first medication treatment parameter profile trace line comprising a medication axis over a time scale, the time scale represented by at least one time axis;

a modified second medication treatment parameter profile trace line comprising the medication axis over the time scale, the modified second medication treatment parameter profile based on a detected user modification to the first medication treatment parameter profile trace line;

a first physiological profile trace line associated with the medication treatment parameter profile, the first physiological profile trace line comprising a physiological profile axis over the time scale; and

a modified second physiological profile trace line comprising the physiological profile axis over the time scale, the modified second physiological profile trace based on a determined corresponding modification to the medication treatment parameter profiled due to the detected user modification to the first medication treatment parameter profile trace line.

15. The system of claim 14, wherein the medication treatment parameter profile is selected from the group consisting of a basal insulin rate profile, an insulin sensitivity profile, an insulin to carbohydrate ratio, a meal event, or a bolus insulin event.

16. The system of claim 14, wherein the physiological profile is selected from the group consisting of a glucose level profile, an oxygen level profile, or a blood pressure level profile.

17. The system of claim 14, further comprising a data transmitter configured to transmit the information corresponding to the detected glucose level from the analyte sensor and to the data receiver over the communication link.

18. The system of claim 14, wherein the communication link is a Bluetooth communication link.

19. A system comprising:

a display unit;

one or more processors and a memory communicatively coupled to the display unit, wherein the memory stores instructions that, when executed by the one or more processors, causes the one or more processors to simultaneously display on the display unit;

a first medication treatment parameter profile trace line comprising a medication axis over a time scale, the time scale represented by at least one time axis;

a modified second medication treatment parameter profile trace line comprising the medication axis over the time scale, the modified second medication treatment parameter profile based on a detected user modification to the first medication treatment parameter profile trace line;

a first physiological profile trace line associated with the medication treatment parameter profile, the first physiological profile trace line comprising a physiological profile axis over the time scale; and

a modified second physiological profile trace line comprising the physiological profile axis over the time scale, the modified second physiological profile trace based on a determined corresponding modification to the medication treatment parameter profiled due to the detected user modification to the first medication treatment parameter profile trace line.

20. The system of claim 19, wherein the modified second physiological profile trace comprises a modified analyte level, and further comprising a medication delivery device communicatively coupled with a data receiver and configured to deliver medication to a user'"'"'s body based on information corresponding to a detected analyte level of the user from an analyte sensor and the modified analyte level.